Heneicosanoic acid

CAS No. 2363-71-5

Heneicosanoic acid ( Heneicosylic Acid;C21:0 )

Catalog No. M20013 CAS No. 2363-71-5

Heneicosanoic acid (HEA) is a fatty acid found in human milk fat. HEA is also a part of the phospholipids of the articular cartilage boundary lubricant. HEA is a constituent of red blood cell fatty acids.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 77 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Heneicosanoic acid
  • Note
    Research use only not for human use.
  • Brief Description
    Heneicosanoic acid (HEA) is a fatty acid found in human milk fat. HEA is also a part of the phospholipids of the articular cartilage boundary lubricant. HEA is a constituent of red blood cell fatty acids.
  • Description
    Heneicosanoic acid (HEA) is a fatty acid found in human milk fat. HEA is also a part of the phospholipids of the articular cartilage boundary lubricant. HEA is a constituent of red blood cell fatty acids.
  • Synonyms
    Heneicosylic Acid;C21:0
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2363-71-5
  • Formula Weight
    326.56
  • Molecular Formula
    C21H42O2
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 20 mg/mL;DMSO: Soluble
  • SMILES
    CCCCCCCCCCCCCCCCCCCCC(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Mosley EE et al. trans Fatty acids in milk produced by women in the United States. Am J Clin Nutr. 2005 Dec;82(6):1292-7.
molnova catalog
related products
  • (+)-Dehydroabietic a...

    (+)-Dehydroabietic acid is a natural compound isolated from Rosin acid.

  • Esfenvalerate

    Esfenvalerate is a widely used insecticide.

  • GSK329

    GSK329 is an effective and selective inhibitor of TNNI3 Interacting Kinase (TNNI3K). GSK329 exhibits positive cardioprotective outcomes in the model of ischemia/reperfusion cardiac injury.